 | News Release 
FDA Clears Cellulite Claims for Dynatronics' Synergie
Device
Salt Lake City, Utah
(March 25, 1999) -- Dynatronics corporation (NASDAQ:DYNT) today announced that
the United States Food and Drug Administration (FDA) has given formal clearance
to expand labeling claims for the company's Synergie AMS device to include the
claim of "temporary reduction in the appearance of cellulte."
"After working with
the FDA for seven months," said Kelvyn H. Cullimore, Jr., President of
Dynatronics, "we can now actively promote the Synergie AMS device for one
of its most effetive uses: reducing the appearance of cellulite. This claim is strongly supported by our
research study, which revealed that 91 percent of the participants reported a
favorable reduction in the appearance of cellulite." |
| The Synergie Lifestyle
System utilizes non-invasive vacuum technology to massage the skin and
subcutaneous tissues in common cellulite problem areas such as thighs, hips,
and buttocks. Since the product's
introduction to the market in July 1998, hundreds of Synergie units have been
sold domestically and internationally. |
|
Beardall, Executive Vice President of Sales and Marketing at Dynatronics,
thousands of patients have already enjoyed the benefits of the Synergie
treatments, and many have reported losing six, eight, and even twelve inches
off their thighs, hips, and waist combined.
"With the clearance
of this additional claim, our ability to more effectively promote this product
and generate enthusiasm for it's potential in the marketplace will be greatly
enhanced." Beardall explained.
| Sales for the third
quarter ending March 31, 1999 are expected to increase 11 percent over the same
period a year ago. Changes in Medicare
reimbursement (effective January 1, 1999) slowed overall sales, dampening the
previously anticipated sales growth for the quarter. Consequently, third-quarter earnings are
predicted to trail second-quarter results. Dynatronics manufacturers,
markets, and distributes advanced-technology medical devices, orthopedic soft
goods and supplies, nutritional supplements, treatment tables, and
rehabilitation equipment for the physical therapy, sports medicine
chiropractic, podiatry, plastic surgery, dermatology, and other related
medical, cosmetic, and aesthetic markets.
| | |
